Biotechnology

Applied Genetic Technologies

$4.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.42%) As of 3:10 PM UTC today

Why Robinhood?

You can buy or sell AGTC and other stocks, options, and ETFs commission-free!

About AGTC

Applied Genetic Technologies Corporation Common Stock, also called Applied Genetic Technologies, is a clinical stage biotechnology company, which engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. The listed name for AGTC is Applied Genetic Technologies Corporation Common Stock.

CEO
Susan B. Washer
Employees
83
Headquarters
Alachua, Florida
Founded
1999
Market Cap
125.80M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
198.72K
High Today
$4.89
Low Today
$4.72
Open Price
$4.82
Volume
45.26K
52 Week High
$8.45
52 Week Low
$2.29

Collections

AGTC Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Feb 4, After Hours

You May Also Like

INDO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure